Malingered neurocognitive dysfunction in neurotoxic exposure: an application of the Slick criteria

Kevin J Bianchini1, Rebecca J Houston, Kevin W Greve

  • 1Department of Psychology, University of New Orleans, New Orleans, LA 70148, USA.

Insights

Differentiating true cognitive deficits from malingering in toxic tort cases is crucial. This study applies the Slick Criteria to four patients, highlighting the need for coordinated expert evaluation in neurotoxic exposure claims.

Area of Science:

  • Neuroscience
  • Toxicology
  • Forensic Psychology

Background:

  • Toxic tort litigation is rising, making accurate assessment of neurocognitive damages critical.
  • Distinguishing genuine deficits from malingering in neurotoxic exposure cases presents a significant challenge due to limited research.

Observation:

  • Four patients presented with cognitive deficits following alleged occupational neurotoxic exposure.
  • These patients were diagnosed with malingering using the Slick, Sherman, and Iverson criteria.

Findings:

  • The study illustrates the practical application of the Slick Criteria in evaluating malingering.
  • It reviews current knowledge on neurotoxic substances' effects on cognitive function and their impact on clinical assessments.

Implications:

  • Findings underscore the importance of robust malingering detection methods in toxic tort cases.
  • A proposed paradigm emphasizes collaborative evaluation by medical, toxicological, and neuropsychology professionals for alleged neurotoxic exposures.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...